Approach to Neurological Channelopathies and Neurometabolic Disorders in Newborns

Inn-Chi Lee1,2

  • 1Division of Pediatric Neurology, Department of Pediatrics, Chung Shan Medical University Hospital, Taichung 40201, Taiwan.

Life (Basel, Switzerland)
|November 27, 2021
PubMed

Insights

Newborns with channelopathies can experience seizures mimicking neurometabolic disorders. Early diagnosis is crucial for neurodevelopmental outcomes in these critical infant channelopathies.

Area of Science:

  • Neonatal neurology
  • Genetics
  • Pediatric epilepsy

Background:

  • Ion channel disorders (channelopathies) affect newborns, impacting the central nervous system and skeletal muscle.
  • Neonatal seizures are a key manifestation, often presenting similarly to neurometabolic disorders.
  • Seizure severity varies, from mild to severe epileptic encephalopathies with potential developmental regression and mortality.

Purpose of the Study:

  • To highlight the diagnostic challenges of channelopathies in newborns.
  • To emphasize the importance of distinguishing channelopathies from neurometabolic disorders.
  • To underscore the need for early and accurate diagnosis for improved neurodevelopmental outcomes.

Main Methods:

  • Review of clinical presentations of channelopathies in neonates.
  • Comparison of seizure characteristics between channelopathies and neurometabolic disorders.
  • Discussion of diagnostic strategies for differentiating these conditions.

Main Results:

  • Channelopathies present with focal or generalized seizures in newborns.
  • Clinical presentation can closely mimic neurometabolic disorders, complicating diagnosis.
  • Delayed diagnosis can lead to adverse neurodevelopmental consequences.

Conclusions:

  • Early identification of channelopathies in newborns is critical.
  • A systematic diagnostic approach is essential to differentiate from neurometabolic disorders.
  • Timely diagnosis and management improve long-term neurodevelopmental prognosis for affected infants.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
301
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
27
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
3.9K